Phibro Animal Health Corp Class A (PAHC) financials

NASDAQ · Health Care

$38.88 +0.05% Close Oct 30, 2026 Live

Phibro Animal Health revenue and earnings by year

Phibro Animal Health's revenue was $1.52 billion in the fiscal year to June 30, 2026, up 17.1% from the year before. Net income was $99.7 million, 6.6% of revenue. Since the fiscal year to June 30, 2017, revenue has grown 7.9% a year on average.

RevenueNet income
$500M$1.00B$1.50B
2017201820192020202120222023202420252026

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Revenue1.521.301.020.980.940.830.800.830.820.76
Revenue growth17.1%27.4%4.1%3.8%13.1%4.1%-3.3%1.0%7.3%—
Gross profit0.510.400.310.300.290.270.260.260.270.25
Gross margin33.8%30.9%30.8%30.5%30.3%32.6%32.1%32.0%32.5%32.5%
Operating income0.190.110.050.070.080.070.070.080.100.10
Operating margin12.8%8.5%5.2%7.3%8.4%9.0%8.6%10.1%12.1%12.8%
Net income0.100.050.000.030.050.050.030.050.060.06
Net margin6.6%3.7%0.2%3.3%5.2%6.5%4.2%6.6%7.9%8.5%
Diluted EPS$2.43$1.19$0.06$0.81$1.21$1.34$0.83$1.35$1.61$1.61
Free cash flow0.010.040.05-0.04-0.010.020.030.020.050.08

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PAHC in Markets.

See also: PAHC valuation and P/E history · PAHC returns

No forecast, no recommendation. This page describes Phibro Animal Health Corp Class A from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.